MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517094010 A) filed by Beone Medicines I Gmbh, Basel, Switzerland, on Sept. 30, for 'anti-cldn6 and anti-cd3 multispecific antibodies and methods of use.'
Inventor(s) include Wan, Zhitao; Li, Dan; Tang, Xiaoyan; Chen, Yun; Lei, Ming; Shao, Ting; Xue, Liu; Ding, Yao; Ji, Ruyue; Xu, Qiming; and Guo, Hui.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure provides for multi-specific antibodies and antigen-binding fragments thereof that bind to human CLDN6 and CD3, a pharmaceutical composition comprising said antibody or antigen-binding fragments thereof, and use of the multi-specific antibody or antigen-binding fragments thereof or the composition for treating a disease, such as cancer."
The patent application was internationally filed on Mar. 05, 2024, under International application No.PCT/IB2024/052124.
Disclaimer: Curated by HT Syndication.
